446 related articles for article (PubMed ID: 20402554)
1. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.
Dorsey P; Keel C; Klavens M; Hellstrom WJ
Expert Opin Pharmacother; 2010 May; 11(7):1109-22. PubMed ID: 20402554
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
Carson CC; Lue TF
BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 5 inhibitors for erectile dysfunction.
Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of erectile dysfunction in man.
Cirino G; Fusco F; Imbimbo C; Mirone V
Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
[TBL] [Abstract][Full Text] [Related]
5. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review.
Rambhatla A; Kovanecz I; Ferrini M; Gonzalez-Cadavid NF; Rajfer J
Int J Impot Res; 2008; 20(1):30-4. PubMed ID: 17673932
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of phosphodiesterase 5 inhibitors.
Carrier S
Can J Urol; 2003 Feb; 10 Suppl 1():12-6. PubMed ID: 12625845
[TBL] [Abstract][Full Text] [Related]
7. PDE5 inhibitors: are there differences?
Carson CC
Can J Urol; 2006 Feb; 13 Suppl 1():34-9. PubMed ID: 16526979
[TBL] [Abstract][Full Text] [Related]
8. The evolving role of testosterone in the treatment of erectile dysfunction.
Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
[TBL] [Abstract][Full Text] [Related]
9. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Sperling H; Lümmen G; Schneider T; Rübben H
Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
[TBL] [Abstract][Full Text] [Related]
10. [Update of PDE5 inhibitors for the treatment of ischemia-reperfusion].
Hu YY; Wu ZG
Zhonghua Nan Ke Xue; 2011 Sep; 17(9):842-6. PubMed ID: 21961251
[TBL] [Abstract][Full Text] [Related]
11. Newer phosphodiesterase inhibitors: comparison with established agents.
McNamara ER; Donatucci CF
Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
13. Comparison of phosphodiesterase type 5 (PDE5) inhibitors.
Wright PJ
Int J Clin Pract; 2006 Aug; 60(8):967-75. PubMed ID: 16780568
[TBL] [Abstract][Full Text] [Related]
14. [Whole rehabilitation: a new goal of erectile dysfunction therapy].
Zhang K
Zhonghua Nan Ke Xue; 2006 Sep; 12(9):832-5. PubMed ID: 17009539
[TBL] [Abstract][Full Text] [Related]
15. [Update of PDE5 inhibitors as treatment of ED].
Lu YN; Chen B
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
[TBL] [Abstract][Full Text] [Related]
16. [Novel indications for phosphodiesterase type 5 inhibitors].
Rosenkranz S; Caglayan E; Erdmann E
Med Klin (Munich); 2007 Aug; 102(8):617-30. PubMed ID: 17694282
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic dilemma: how to use short-acting PDE5 inhibitor drugs.
Fabbri A; Aversa A
Int J Androl; 2005 Dec; 28 Suppl 2():69-73. PubMed ID: 16236069
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil for erectile dysfunction.
Drug Ther Bull; 1998 Nov; 36(11):81-4. PubMed ID: 10562764
[TBL] [Abstract][Full Text] [Related]
20. Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors.
Hellstrom WJ
Int J Clin Pract; 2007 Sep; 61(9):1547-54. PubMed ID: 17655683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
